Your browser doesn't support javascript.
loading
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial.
Riely, Gregory J; Neal, Joel W; Camidge, D Ross; Spira, Alexander I; Piotrowska, Zofia; Costa, Daniel B; Tsao, Anne S; Patel, Jyoti D; Gadgeel, Shirish M; Bazhenova, Lyudmila; Zhu, Viola W; West, Howard L; Mekhail, Tarek; Gentzler, Ryan D; Nguyen, Danny; Vincent, Sylvie; Zhang, Steven; Lin, Jianchang; Bunn, Veronica; Jin, Shu; Li, Shuanglian; Jänne, Pasi A.
Afiliación
  • Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York. rielyg@MSKCC.ORG.
  • Neal JW; Department of Medicine, Division of Oncology, Stanford University, Stanford, California.
  • Camidge DR; Department of Medicine, Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado.
  • Spira AI; Department of Thoracic Oncology, Virginia Cancer Specialists, Fairfax, Virginia.
  • Piotrowska Z; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Costa DB; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Tsao AS; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel JD; Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.
  • Gadgeel SM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan.
  • Bazhenova L; Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.
  • Zhu VW; Department of Medicine, Division of Hematology/Oncology, University of California, Irvine, Orange, California.
  • West HL; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Mekhail T; Thoracic Cancer Program, AdventHealth Orlando, Orlando, Florida.
  • Gentzler RD; Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, Virginia.
  • Nguyen D; Department of Hematology and Oncology, Pacific Shores Medical Group, Long Beach, California.
  • Vincent S; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Zhang S; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Lin J; Statistical and Quantitative Sciences, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Bunn V; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Jin S; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Li S; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer Discov ; 11(7): 1688-1699, 2021 07.
Article en En | MEDLINE | ID: mdl-33632775
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirimidinas / Exones / Carcinoma de Pulmón de Células no Pequeñas / Indoles / Compuestos de Anilina / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Discov Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirimidinas / Exones / Carcinoma de Pulmón de Células no Pequeñas / Indoles / Compuestos de Anilina / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Discov Año: 2021 Tipo del documento: Article